biologics

In just a decade, India’s bioeconomy has expanded from USD 10 billion in 2014 to over USD 165 billion in 2024, now contributing…

India has earned global recognition for making affordable medicines available at scale. But the big question now is: can India…

ICON, a US-based construction company in collaboration with the Confederation of Indian Industry (CII ) Telangana, recently…

GlobalData survey uncovers stark regional differences in physician support for patient involvement in choosing between biologics…

Precision medicine and biologics drive a paradigm shift in COPD treatment across the US, EU5, and Japan, but pricing pressures and…

GlobalData highlights how OX40 inhibitors, led by rocatinlimab, could reshape moderate-to-severe atopic dermatitis treatment by…

The new site will increase Syngene’s total single-use bioreactor capacity to 50,000L for large molecule discovery, development,…

Insights from experts in the field highlight the urgent need for improved diagnostic tools and targeted therapies to address this…

Barriers such as cost and accessibility highlight the urgent need for equitable healthcare solutions to ensure widespread adoption…

The partnership will add to Jubilant Biosys' drug discovery and preclinical development capabilities in biologics and antibody…